Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: Rande Is who wrote (21978)	3/9/2000 8:12:00 AM
From: Trumptown	Read Replies (1) \| Respond to of 57584

Rande, snagged this off Yahoo...good stuff! theglobeandmail.com "Corel and Intel discuss alliance In talks with computer maker to launch cheap line of PCs that would challenge Microsoft's dominance SIMON TUCK Technology Reporter Thursday, March 9, 2000 Ottawa -- Corel Corp. is in talks with Intel Corp. and at least one major computer maker to launch a line of cheap personal computers that takes direct aim at Microsoft Corp.'s near-monopoly in desktop PC operating systems. "There are lots of discussions under way," Corel head Michael Cowpland told The Globe and Mail yesterday, just before the start of the Ottawa software maker's annual general meeting. "We've been talking for months." Mr. Cowpland said the talks are "multifaceted" and involve other computer industry players. Although he wouldn't reveal further details, Corel and Santa Clara, Calif.-based Intel would likely also want to include a computer maker, a browser company and an Internet service provider. "There's a huge amount of action." Under the deal being discussed, Corel will supply its Linux operating system, a cheap and reliable alternative to Microsoft's dominant Windows software. There are no details on what the hardware component of the computer would be, but Intel markets a line of low-cost microprocessors called Celeron. Doug Cooper, a spokesman for Santa Clara, Calif.-based Intel, said the two companies have been working together for "quite some time," but that the key relationship in the arrangement would involve Corel and a computer maker. "We want to ensure that the mainstream software works best with Intel chips." A definitive deal would be a technology industry landmark because it would mark a new path for Intel, which has made its name -- and its vast fortune -- largely on the back of its lucrative relationship with Microsoft. The two giants have dominated their respective areas of the PC industry through a partnership commonly known as "Wintel." But Mr. Cooper said Intel believes in choice. "It's certainly good news for consumers," he said of the talks. There is no indication that Intel plans to sever or scale back its relationship with Microsoft of Redmond, Wash. For Corel, a deal would mark its latest -- and easily most important -- step in the company's strategy of increasing its user base by bundling low-cost versions of its software with the major players in other corners of the PC industry. But a deal would also mark a return to a head-on confrontation with Microsoft, a strategy that sent Corel into a tailspin in the mid-1990s as it attacked the software giant's entrenched position in the office software market. Deal update Corel, Inprise won't adjust merger"

To: Rande Is who wrote (21978)	3/9/2000 8:48:00 AM
From: Rande Is	Read Replies (2) \| Respond to of 57584

Integrated Surgical Systems Announces Planned Date for First Worldwide Robotic Total Knee Replacement Surgery DAVIS, Calif., March 9 /PRNewswire/ -- Integrated Surgical Systems, Inc. (ISS) (Nasdaq: RDOC; EASDAQ), a pioneer in medical robotics and the world leader in image-directed, robotic products for surgical applications in the fields of neurological and orthopedic surgeries, today announced the date for the first worldwide robotic Total Knee Replacement surgery with its ROBODOC(R) surgical assistant system. The first robotic Total Knee Replacement surgery is planned for the week of May 1, 2000. The surgery will be performed at Berufsgenossenschaftliche Unfallklinik (BGU) in Frankfurt. Prof. Dr. Borner of BGU and Prof. Dr. Hennig of University of Erlangen in Germany will perform the surgery. Commenting on the surgery date, Ramesh Trivedi, Ph.D., CEO and President of ISS, stated, "The exact date of the surgery is still not finalized and will be announced later as development efforts reach completion. It has always been ISS' philosophy that nothing is more important than the safety of a patient. ISS will not conduct business in a way that might jeopardize the safety of any patient at any time with our products." Dr. Trivedi also added, "This is a major milestone for ISS and the orthopedic industry. Robot-assisted surgeries for primary and revision hip surgery are now routinely performed with our ROBODOC(R) system. The Total Knee surgery calls for a greater degree of accuracy than the total hip surgery. The ROBODOC(R) system will prove to be even more clinically helpful. A series of cadaver studies performed at Buffalo General Hospital by Prof. Ken Krackow was very impressive to the entire knee surgical team that has been working with us during the entire development phase." When asked whether freehand navigational system or a new robot will be required to perform the knee surgery, Dr. Trivedi commented, "Definitely not. In fact, no major changes from the current configuration of the ROBODOC(R) system are anticipated. We have made certain that as little a change as possible will be necessary to upgrade the current ROBODOC(R) system. These will be retrofitted in the field. Hip and knee represent over 80% of all joint replacement surgeries performed on a worldwide basis. Thus, the ROBODOC(R) system will soon be able to assist the orthopaedic surgeon with most of his surgeries." Dr. Trivedi ended with, "In summary, we are the world leader and with the availability of the Total Knee Replacement surgical application, we will maintain our reputation as the most innovative company." The Products ROBODOC(R) is the ISS robot assisted surgery product that is used in total hip arthroplasty. ROBODOC(R) consists of a robotic arm assembly and a computer-based control system. The product interfaces with its Orthodoc(R) Pre-Surgical Planning System. ISS has installed 37 ROBODOC(R) systems worldwide. The ISS neurosurgery product, NeuroMate(TM), is the first robotic technology for use in stereotactic brain surgery. NeuroMate(TM) consists of a robotic arm assembly that interfaces with its VoXim Pre-Surgical Planning System. It also interfaces with other popular third-party planning stations. ISS has installed 16 NeuroMate(TM) systems worldwide. The Company Integrated Surgical Systems, Inc. develops, manufactures, markets and services computer-controlled, image-directed robotic products for surgical applications. ISS produces the ROBODOC(R) Surgical Assistant System (ROBODOC), which is designed for orthopedic applications. The ROBODOC System has been used to perform precise total hip replacement surgeries on more than 6,000 patients worldwide. ROBODOC is currently being marketed in Europe and the Middle East. NeuroMate(TM), ISS's neurosurgery product, is the first robotic technology for use in stereotactic brain surgery. ISS has installed 16 NeuroMate(TM) systems in the U.S., France, Middle East, and Japan, which have supported neurosurgical procedures on more than 2,000 patients, to date. Except for the historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties, including the timely development and market acceptance of new products and upgrades to existing products, the impact of competitive products and pricing, and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission (SEC). Note: ROBODOC(R) is a registered trademark of Integrated Surgical Systems, Inc. NeuroMate(TM) is a trademark of Integrated Surgical Systems, S.A. For more information on Integrated Surgical Systems via fax at no cost, please call (800) PRO-INFO (732-544-2850 outside the U.S.), ticker symbol RDOC. SOURCE Integrated Surgical Systems, Inc.